Skip to main content

Hibiclens News

Universal Decolonization at Nursing Homes Beneficial

WEDNESDAY, Oct. 18, 2023 – Universal decolonization with chlorhexidine and nasal iodophor in nursing homes leads to a significantly lower risk for transfer to a hospital due to infection, according...

FDA Medwatch Alert: Sunstar Americas Inc. Issues Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination

Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 – 9/30/22 (see specific lots below) to the ...

FDA Medwatch Alert: Chlorhexidine Gluconate: Drug Safety Communication - Rare But Serious Allergic Reactions

ISSUE: FDA is warning that rare but serious allergic reactions have been reported with the widely used skin antiseptic products containing chlorhexidine gluconate. Although rare, the number of...

FDA Medwatch Alert: Over-the-Counter Topical Antiseptic Products: Drug Safety Communication - FDA Requests Label Changes and Single-Use Packaging to Decrease Risk of Infection

ISSUE: The U.S. Food and Drug Administration (FDA) is requesting label and packaging changes to enhance the safe use of certain over-the-counter (OTC) topical antiseptic products. This request is the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Hibiclens patient information at Drugs.com